Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Apomorphine (oromucosal use)

EU orphan designation number: EU/3/01/072
Active ingredient: Apomorphine (oromucosal use)
Indication: Treatment of off-periods in Parkinson's disease not responding to other oral treatment
Sponsor: Orion Corporation
Orionintie 1, 02200 Espoo, Suomi

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/12/2001 Orphan designation EMEA/OD/027/01 (2001)4024 of 05/12/2001
25/02/2005 Removal of orphan designation from Community Register